Hospital operators directory 2026
Private Hospital Groups in Saudi Arabia
Saudi Arabia has the largest and fastest-consolidating private hospital sector in the Middle East: eight groups listed on Tadawul run more than 60 hospitals between them, and Vision 2030’s health transformation is deliberately shifting volume from the Ministry of Health to private operators and insurers.
The Kingdom operates around 500 hospitals and 80,000 beds, roughly 60% of them under the Ministry of Health, with the remainder split between other government systems — National Guard Health Affairs, King Faisal Specialist Hospital, Armed Forces and Aramco — and a private sector that now delivers most insured care for the 11 million people covered under the Council of Health Insurance. Private groups have raised capital through IPOs, acquisitions and sukuk to build hospital clusters in Riyadh, Jeddah, Dammam and the growing secondary cities, while the Health Holding Company reorganises public provision into regional clusters that buy some services privately. This directory lists the private hospital groups and operators that matter for a pharmaceutical, medical device or diagnostics company, alongside the public systems and payers that shape their formularies and purchasing.
~500
Hospitals nationwide, about 170 of them private
~11m
Residents covered by mandatory private health insurance
8
Hospital operators listed on Tadawul, the most of any regional exchange
2030
Vision 2030 target year for private-sector delivery of a larger share of care
Top private hospital groups and operators in Saudi Arabia
Public, well-known names BioNixus studies at account and SKU level. This is an editorial snapshot, not an endorsement or a market-share ranking. Cross-checked against Ministry of Health Statistical Yearbook and Council of Health Insurance — licensed private hospitals and insured population (as of 2026-09-03).
| Company | HQ |
|---|---|
| Dr. Sulaiman Al Habib Medical Group (HMG) | Riyadh |
| Mouwasat Medical Services | Dammam |
| Dallah Health (Dallah Healthcare) | Riyadh |
| Fakeeh Care Group (Dr. Soliman Fakeeh Hospital) | Jeddah |
| Saudi German Health (Batterjee Group) | Jeddah |
| Almoosa Health | Al Ahsa |
| Al Hammadi Holding | Riyadh |
| National Medical Care Company (Care) | Riyadh |
| Specialized Medical Company (SMC) | Riyadh |
| Andalusia Health | Jeddah |
| Kingdom Hospital and Consulting Clinics | Riyadh |
| Ministry of Health / Health Holding Company | Riyadh |
| King Faisal Specialist Hospital & Research Centre | Riyadh |
| National Guard Health Affairs and Johns Hopkins Aramco Healthcare | Riyadh / Dhahran |
| Bupa Arabia and Tawuniya | Jeddah / Riyadh |
These are the hospital operators we work with in Saudi Arabia
Selling into private hospitals in Saudi Arabia? BioNixus runs procurement-committee interviews, formulary-listing studies and KOL mapping across the groups above. Proposal ready within 48 hours of a brief.
Planning research in Saudi Arabia?
Primary research, market access & HEOR. Proposals within 48 hours.
How private hospital provision works in Saudi Arabia
The private sector is organised around integrated groups rather than single hospitals. Dr. Sulaiman Al Habib Medical Group is the largest by revenue and market value, with more than 20 hospitals and medical centres in Riyadh, Jeddah, the Eastern Province and Dubai, its own pharmacy chain and central procurement that negotiates directly with manufacturers. Mouwasat dominates the Eastern Province and Jubail, Dallah Health is a Riyadh anchor with new capacity in Namar and Al Kharj, Fakeeh Care Group and Saudi German Health are Jeddah-rooted groups with national expansion, Almoosa Health leads Al Ahsa, Al Hammadi operates three Riyadh hospitals, National Medical Care serves Riyadh and Jeddah, and Specialized Medical Company added a Riyadh cluster to the listed roster in 2024. Demand is funded mainly by insurers — Bupa Arabia and Tawuniya hold most of the market — whose networks, formularies and pre-authorisation rules determine which hospitals and which brands are reimbursed, and by cash-paying patients for elective care. Public systems remain the largest buyers of medicines and devices through NUPCO’s central tenders, and the Health Holding Company is contracting private groups to run services for its clusters, so the boundary between public and private is blurring. For a manufacturer this means three doors: group-level procurement and formulary committees at the listed operators, insurer formularies that decide reimbursement, and NUPCO for public volumes, each with distinct pricing and evidence expectations.
Local
Saudi-owned hospital groups, most of them Tadawul-listed, and the domestic insurers whose networks fund the majority of private care.
- ✓ Bupa Arabia and Tawuniya
Multinational
International operators participate mainly through management contracts, academic affiliations and joint ventures rather than owning Saudi hospital networks outright.
Regional
Gulf and MENA groups such as Andalusia and Saudi German that operate across borders, linking Saudi hospitals to Egypt, the UAE and beyond.
- ✓ Andalusia Health
Operators, insurers & public systems
The Ministry of Health clusters, specialist government hospitals and NUPCO tenders that remain the largest buyers of medicines and devices.
- ✓ Dr. Sulaiman Al Habib Medical Group (HMG)
- ✓ Mouwasat Medical Services
- ✓ Dallah Health (Dallah Healthcare)
- ✓ Fakeeh Care Group (Dr. Soliman Fakeeh Hospital)
- ✓ Saudi German Health (Batterjee Group)
- ✓ Almoosa Health
- ✓ Al Hammadi Holding
- ✓ National Medical Care Company (Care)
- ✓ Specialized Medical Company (SMC)
- ✓ Kingdom Hospital and Consulting Clinics
- ✓ Ministry of Health / Health Holding Company
- ✓ King Faisal Specialist Hospital & Research Centre
- ✓ National Guard Health Affairs and Johns Hopkins Aramco Healthcare
What is moving hospital provision in Saudi Arabia
Vision 2030 health transformation
Corporatisation of public hospitals into clusters under the Health Holding Company and expanded private-sector contracting shift volume and procurement toward private operators.
Insurance coverage expansion
Growth in mandatory insurance for private-sector employees, dependants and visitors enlarges the insured pool that funds private hospital admissions and outpatient prescriptions.
Capital-market funding
Four hospital IPOs since 2023 and active sukuk issuance give groups capital for new hospitals in Riyadh, Jeddah, Khobar and secondary cities.
Medical tourism and specialty care
Government programmes to attract regional patients and localise oncology, cardiac and IVF care raise demand for premium therapies and devices in private tertiary hospitals.
How BioNixus studies private hospital groups and operators in Saudi Arabia
The accounts above are the ones our field teams and analysts work with. What a brand team typically commissions from us in Saudi Arabia:
- ✓Formulary and procurement decision mapping at Al Habib, Mouwasat, Dallah, Fakeeh and Saudi German, and at King Faisal Specialist Hospital and National Guard Health Affairs.
- ✓KOL, pharmacy director and supply-chain interviews on tender behaviour, brand preference and NUPCO dynamics.
- ✓Insurer-network and pre-authorisation research with Bupa Arabia, Tawuniya and TPAs on reimbursement of specialty therapies.
- ✓Patient pathway studies across Riyadh, Jeddah and the Eastern Province in oncology, cardiology, diabetes and IVF.
Frequently Asked Questions
Which are the largest private hospital groups in Saudi Arabia?
Dr. Sulaiman Al Habib Medical Group leads, followed by Mouwasat, Dallah Health, Fakeeh Care, Saudi German Health, Almoosa, Al Hammadi, National Medical Care and Specialized Medical Company, all listed on Tadawul.
Who pays for private hospital care in Saudi Arabia?
Mainly private health insurers led by Bupa Arabia and Tawuniya under the Council of Health Insurance framework, plus cash patients and, increasingly, government contracts for services delivered privately.
How do hospital groups buy medicines and devices?
Listed groups run central procurement and formulary committees that negotiate with manufacturers and agents; public systems buy through NUPCO tenders, and insurer formularies determine reimbursement in the private channel.
What is the Health Holding Company?
The entity created under Vision 2030 to take over Ministry of Health hospitals and run them as regional health clusters with purchaser–provider separation and private-sector contracting.
What does BioNixus study about hospital groups in Saudi Arabia?
Formulary and procurement decision mapping at listed groups and government hospitals; KOL and pharmacy director interviews; patient pathway and insurer-network research; and account-level brand share tracking across hospital clusters.
Is this a ranking of the best hospitals?
No. This is a B2B directory of operators grouped by role, included because they recur in BioNixus Saudi fieldwork and Council of Health Insurance and Tadawul records; order does not indicate quality or size.
Data sources & methodology
This directory aggregates publicly available company and channel facts — filings, brand sites, and BioNixus fieldwork in Saudi Arabia. It is an editorial snapshot of the accounts we study, not a share ranking and not a substitute for NielsenIQ, IQVIA, or another syndicated feed.
Primary register: Ministry of Health Statistical Yearbook and Council of Health Insurance — licensed private hospitals and insured population, consulted 2026-09-03. Company classification (Local / MNC / Regional / operators, insurers & public systems) reflects ownership and role in Saudi Arabia, not size.
- Ministry of Health Statistical Yearbook, 2023 edition published 2024
- Council of Health Insurance annual report and insured population statistics, 2024
- Tadawul annual reports of HMG, Mouwasat, Dallah, Fakeeh Care, Middle East Healthcare, Almoosa, Al Hammadi, Care and SMC, 2024–2025
- BioNixus Saudi hospital and payer fieldwork, 2023–2026
BioNixus sells account-level and SKU-level primary research that complements those subscriptions. For a scoped proposal, contact the team or use the form below. Email admin@bionixus.com.
Need hospital-level data in Saudi Arabia?
Procurement pathways, formulary status, device usage and clinician preference by operator — fielded with the people who make the decisions.
Planning research in Saudi Arabia?
Primary research, market access & HEOR. Proposals within 48 hours.